-
1Academic Journal
Authors: Муравьев Ю.В., Лебедева В.В.
Subject Terms: вакцинация, аутоиммунные ревматические заболевания, фармакологический надзор
Relation: https://zenodo.org/records/5136594; oai:zenodo.org:5136594; https://doi.org/10.5281/zenodo.5136594
-
2Academic Journal
-
3Academic Journal
Authors: D. V. Bukhanova, B. S. Belov, Д. В. Буханова, Б. С. Белов
Source: Modern Rheumatology Journal; Том 10, № 3 (2016); 69-76 ; Современная ревматология; Том 10, № 3 (2016); 69-76 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2016-3
Subject Terms: вакцинация, comorbid infections, comorbidity, autoimmune rheumatic diseases, rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, biological agents, vaccination, коморбидные инфекции, коморбидность, аутоиммунные ревматические заболевания, ревматоидный артрит, системная красная волчанка, дерматомиозит, генно-инженерные биологические препараты
File Description: application/pdf
Relation: https://mrj.ima-press.net/mrj/article/view/704/685; Kaslow RA, Stanberry LR, LeDuc JW. Viral infection of humans: epidemiology and controls. 5th ed. New York: Springer Science Business Media; 2014. P. 971-96.; Chen N, Li Q, Zhang Y, et al. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007795. doi:10.1002/14651858. CD007795.pub2.; U.S. Department of Health & Human Services, Shingles (Herpes Zoster). http://www.cdc.gov/shingles/index.html.; Pinchinat S, Cebrian-Cuenca AM, Bricout H, et al. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013 Apr 10;13:170. doi:10.1186/1471-2334-13-170.; Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014 May 13;348:g2911. doi:10.1136/bmj.g2911.; Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and noninflammatory musculoskeletal disorders. Rheumatology (Oxford). 2006;45(11):1370-5.; Smitten AL, Choi HK, Hochberg MC, et al. The risk of herpes zoster in patientswith rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007 Dec 15;57(8):1431-8.; Widdifield J, Bernatsky S, Paterson JM, et al. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Mar;65(3):353-61. doi:10.1002/acr.21812.; McDonald JR, Zeringue AL, Caplan L, et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis. 2009 May 15;48(10):1364-71. doi:10.1086/598331.; Veetil BM, Myasoedova E, Matteson EL, et al. Incidence and time trends of herpes zoster in rheumatoid arthritis: a populationbased cohort study. Arthritis Care Res (Hoboken). 2013 Jun;65(6):854-61. doi:10.1002/acr.21928.; Nakajima A, Urano W, Inoue E, et al. Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010. Mod Rheumatol. 2015 Jul;25(4):558-61. doi:10.3109/14397595.2014.984829.; Antonelli MA, Moreland LW, Brick JE. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med. 1991;90(3):295-8.; Segan J, Staples MP, March L, et al. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor- α inhibitors. Intern Med J. 2015 Mar; 45(3):310- 8. doi:10.1111/imj.12679.; Strangfeld A, Listing J, Herzer P, et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA. 2009;301(7):737-44.; Pappas DA, Hooper MM, Kremer JM, et al. Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease modifying anti- rheumatic drugs. Arthritis Care Res (Hoboken). 2015 Dec;67(12):1671-8. doi:10.1002/ acr.22628.; Yun H, Xie F, Delzell E, et al. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken). 2015 May;67(5):731-6. doi:10.1002/acr.22470.; Galloway JB, Mercer LK, Moseley A, et al. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2013;72(2):229-34.; Winthrop KL, Baddley JW, Chen L, et al. Association between the initiation of anti- TNF therapy and the risk of herpes zoster. JAMA. 2013 Mar 6;309(9): 887-95. doi:10.1001/jama.2013.1099.; Dewedar AM, Shalaby MA, Al-Homaid S, et al. Lack of adverse effect of anti-tumor necrosis factor-alpha biologics in treatment of rheumatoid arthritis: 5 years follow- up. Int J Rheum Dis. 2012;15(3):330-5.; Wendling D, Streit G, Toussirot E, Prati C. Herpes zoster in patients taking TNFalpha antagonists for chronic inflammatory joint disease. Joint Bone Spine. 2008 Oct;75(5):540-3. doi:10.1016/j.jbspin.2007.10.011. Epub 2008 Jul 31.; Winthrop KL, Yamanaka H, Valdez H, et al. Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2014 Oct;66(10):2675-84. doi:10.1002/art.38745.; Curtis JR, Xie F, Yun H, et al. Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis. Ann Rheum Dis. 2016 Apr 25. pii: annrheumdis-2016-209131. doi:10.1136/annrheumdis-2016-209131. [Epub ahead of print].; Borba EF, Ribeiro AC, Martin P, et al. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus. J Clin Rheumatol. 2010 Apr;16(3):119-22. doi:10.1097/RHU.0b013e3181d52ed7.; Manzi S, Kuller LH, Kutzer J, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol. 1995 Jul;22(7):1254-8.; Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol. 1994 Jan;21(1):84-6.; Moutsopoulos HM, Gallagher JD, Decker JL, et al. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum. 1978 Sep-Oct;21(7):798-802.; Hellman DB, Petri M, Whiting-O’Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore). 1987 Sep;66(5):341-8.; Moga I, Formiga F, Canet R, et al. Herpes-zoster virus infection in patients with systemic lupus erythematosus. Rev Clin Esp. 1995 Aug;195(8):530-3.; Chakravarty EF, Michaud K, Katz R, Wolfe F. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013 Mar;22(3): 238-44. doi:10.1177/0961203312470186.Epub 2012 Dec 20.; Chen HH, Chen YM, Chen TJ, et al. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (Sao Paulo). 2011;66(7):1177-82.; Kang TY, Lee HS, Kim TH, et al. Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus. Rheumatol Int. 2005 Mar;25(2):97-102. Epub 2003 Oct 31. doi:10.1007/s00296-003-0403-3.; Skare TL, Dagostini JS, Zanardi PI, Nisihara RM. Infections and systemic lupus erythematosus. Einstein (Sao Paulo). 2016 Mar;14(1):47-51. doi:10.1590/S1679- 45082016AO3490.; Chakravarty EF, Odell J, Rasmussen A, et al. Varicella Zoster Reactivation in Patients with Primary Sjö gren’s Syndrome and SLE [abstract]. Arthritis Rheumatol. 2015;67 (suppl 10).; Chen JY, Wang LK, Feng PH, et al. Risk of Shingles in Adults with Primary Sjö gren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study. PLoS One. 2015 Aug 25;10(8):e0134930. doi:10.1371/journal.pone.0134930. eCollection 2015.; Tsai SY, Lin CL, Wong YC, et al. Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis. Medicine (Baltimore). 2015 Jul; 94(28): e1138. doi:10.1097/MD.0000000000001138.; Chen IJ, Tsai WP, Wu YJ, et al. Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford). 2010 Dec;49(12):2429-37. doi:10.1093/rheumatology/keq279. Epub 2010 Sep 13.; Fardet L, Rybojad M, Gain M, et al. Incidence, risk factors, and severity of herpesvirus infections in a cohort of 121 patients with primary dermatomyositis and dermatomyositis associated with a malignant neoplasm. Arch Dermatol. 2009 Aug; 145(8):889-93. doi:10.1001/archdermatol.2009.152.; Zisman D, Bitterman H, Shalom G, et al. Psoriatic arthritis treatment and the risk of herpes zoster. Ann Rheum Dis. 2016 Jan;75(1):131-5. doi:10.1136/annrheumdis- 2013- 205148.; Wung PK, Holbrook JT, Hoffman GS, et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. WGET Research Group. Am J Med. 2005 Dec;118(12):1416.; Foocharoen C, Siriphannon Y, Mahakkanukrauh A, et al. Incidence rate and causes of infection in Thai systemic sclerosis patients. Int J Rheum Dis. 2012 Jun;15(3):277-83. doi:10.1111/j.1756-185X.2012.01728.x; Gagliardi AM, Gomes Silva BN, Torloni MR, Soares BG. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2012 Oct 17;10:CD008858. doi:10.1002/14651858. CD008858.pub2.; Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 2;352(22):2271-84.; Schmader KE, Levin MJ, Gnann JW, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50–59years. Clin Infect Dis. 2012 Apr;54(7):922-8. doi:10.1093/cid/cir970. Epub 2012 Jan 30.; Morrison VA, Johnson GR, Schmader KE, et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis. 2015 Mar 15;60(6):900-9. doi:10.1093/cid/ciu918. Epub 2014 Nov 20.; Curtis JR, Turner A, Thomas C, et al. Safety, Clinical and Immunologic Effectiveness of the Live Zoster Vaccine Administered to Patients Receiving Anti- TNF Biologics [abstract]. Arthritis Rheumatol. 2015;67(Suppl 10).; Yun H, Xie F, Baddley J, et al. Long Term Effectiveness of Herpes Zoster Vaccine Among Patients with Autoimmune and Inflammatory Diseases [abstract]. Arthritis Rheumatol. 2015;67(Suppl 10).; Malavige GN, Jones L, Black AP, Ogg GS. Varicella zoster virus glycoprotein Especific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors. Clin Exp Immunol. 2008 Jun;152(3):522-31. doi:10.1111/j.1365-2249.2008.03633.x. Epub 2008 Mar 20.; Laing KJ, Russell RM, Dong L, et al. Zoster vaccination increases the breadth of CD4+ T cells responsive to varicella zoster virus. J Infect Dis. 2015 Oct 1;212(7):1022-31. doi:10.1093/infdis/jiv164. Epub 2015 Mar 17.; Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015 May 28;372(22):2087-96. doi:10.1056/NEJMoa1501184. Epub 2015 Apr 28.; Stadtmauer EA, Sullivan KM, Marty FM, et al. A Phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 2014 Nov 6;124(19):2921-9. doi:10.1182/blood-2014-04-573048. Epub 2014 Sep 18.; Berkowitz EM, Moyle G, Stellbrink HJ, et al. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a Phase 1/2a randomized, placebo-controlled study. J Infect Dis. 2015 Apr 15;211(8):1279-87. doi:10.1093/infdis/jiu606. Epub 2014 Nov 3.
-
4Academic Journal
Authors: Александрова, Елена, Верижникова, Ж., Новиков, А., Баранов, А., Абайтова, Н., Лапкина, Н., Роггенбук, Д., Насонов, Е.
Subject Terms: АНТИНУКЛЕАРНЫЕ АНТИТЕЛА, НЕПРЯМАЯ РЕАКЦИЯ ИММУНОФЛЮОРЕСЦЕНЦИИ, HEP-2-КЛЕТКИ, АВТОМАТИЗИРОВАННАЯ СИСТЕМА ИНТЕРПРЕТАЦИИ КЛЕТОЧНЫХ ФЛЮОРЕСЦЕНТНЫХ ТЕСТОВ, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ
File Description: text/html
-
5Academic Journal
Authors: Ананьева, Лидия, Соловьев, С., Бекетова, Т., Васильев, В., Антелава, О., Александрова, Е., Конева, О., Цанян, М., Десинова, О., Логвиненко, О., Волков, А., Хелковская-сергеева, А., Новиков, А., Алексанкин, А., Насонов, Е.
Subject Terms: ИММУНОВОСПАЛИТЕЛЬНЫЕ (АУТОИММУННЫЕ) РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ, РИТУКСИМАБ, В-ЛИМФОЦИТЫ, IMMUNE INFLAMMATORY (AUTOIMMUNE) RHEUMATIC DISEASES
File Description: text/html
-
6Academic Journal
Authors: Асеева, Елена, Соловьев, С.
Subject Terms: ВНУТРИВЕННЫЙ ИММУНОГЛОБУЛИН, БОЛЕЗНЬ КАВАСАКИ, ДЕРМАТОМИОЗИТ, ИДИОПАТИЧЕСКАЯ ТРОМБОЦИТОПЕНИЧЕСКАЯ ПУРПУРА, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ
File Description: text/html
-
7Academic Journal
Authors: Лапин, Сергей, Маслянский, А., Лазарева, Н., Васильева, Е., Тотолян, А.
Subject Terms: ПРОКАЛЬЦИТОНИН, АМИНОКИСЛОТЫ, РЕВМАТОИДНЫЙ АРТРИТ, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ
File Description: text/html
-
8Academic Journal
Source: Клиническая лабораторная диагностика.
Subject Terms: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, АНТИНУКЛЕАРНЫЕ АНТИТЕЛА, НЕПРЯМАЯ РЕАКЦИЯ ИММУНОФЛЮОРЕСЦЕНЦИИ, HEP-2-КЛЕТКИ, АВТОМАТИЗИРОВАННАЯ СИСТЕМА ИНТЕРПРЕТАЦИИ КЛЕТОЧНЫХ ФЛЮОРЕСЦЕНТНЫХ ТЕСТОВ, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ, 3. Good health
File Description: text/html
-
9Academic Journal
Source: Научно-практическая ревматология.
Subject Terms: ИММУНОВОСПАЛИТЕЛЬНЫЕ (АУТОИММУННЫЕ) РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ, РИТУКСИМАБ, В-ЛИМФОЦИТЫ, IMMUNE INFLAMMATORY (AUTOIMMUNE) RHEUMATIC DISEASES, 3. Good health
File Description: text/html
-
10Academic Journal
Source: Современная ревматология.
Subject Terms: ВНУТРИВЕННЫЙ ИММУНОГЛОБУЛИН, БОЛЕЗНЬ КАВАСАКИ, ДЕРМАТОМИОЗИТ, ИДИОПАТИЧЕСКАЯ ТРОМБОЦИТОПЕНИЧЕСКАЯ ПУРПУРА, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ, 3. Good health
File Description: text/html
-
11Academic Journal
Source: Клиническая лабораторная диагностика.
Subject Terms: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, ПРОКАЛЬЦИТОНИН, АМИНОКИСЛОТЫ, РЕВМАТОИДНЫЙ АРТРИТ, АУТОИММУННЫЕ РЕВМАТИЧЕСКИЕ ЗАБОЛЕВАНИЯ, 3. Good health
File Description: text/html
